Factors affecting adherence to antiretroviral therapy

Clinical Infectious Diseases

Volumn 30, Issue SUPPL. 2, 2000, Pages

  Chesney, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ALCOHOL ABUSE; CONFERENCE PAPER; DIET RESTRICTION; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; SUBSTANCE ABUSE; VIREMIA;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PATIENT COMPLIANCE; RISK FACTORS;

EID: 0034457843     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313849     Document Type: Conference Paper

References (32)

1. Adherence and effectiveness of protease inhibitors in clinical practice
2. Self-reported adherence to ritonavir/saquinavir and ritonavir/saquinavir/stavudine in a randomized clinical trial: Preliminary results
3. Electronic adherence assessment versus self-report in HIV-infected individuals
4. Validity of patient questioning versus pill count as an assessment of compliance
5. Compliance with inhaled medications: The relationship between diary and electronic monitoring
6. Adherence with protease inhibitor therapy for human immunodeficiency virus infection
7. Adherence to antiretroviral therapy among HIV positive women
8. + patients and protease inhibitors
9. Adherence to anti-retroviral therapy: A four country comparison
10. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease
11. A proposed model to predict compliance with antiretroviral therapy
12. Adherence to highly active antiretroviral therapy (HAART)
13. Patterns of self-reported adherence to ART in a prospective clinical cohort
14. Issues regarding anti-retroviral treatment for patients with HIV-1 infection
15. Predictors of non-adherence to HIV combination therapies
16. Self reported treatment adherence and drug/alcohol use are associated with virologic outcomes in CCTG 570: A clinical strategy trial of HIV RNA and antiretroviral monitoring
17. Poor experiences of health care leads to avoidance by HIV-positive gay men in youth, ages 18 to 27, and can influence access and adherence
18. Impact of interventions on adherence rates
19. Self-reported adherence to combination antiretroviral medication regimens in a community-based sample of HIV-infected adults
20. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors
21. Development of the HIV treatment satisfaction survey (HTSS) to improve adherence and quality of outpatient care
22. Comparison between physicians' and patients' advises about adherence to antiretroviral therapies
23. Treatment guidelines in HIV: Self reported physician practices
24. The Midwest AIDS training and education partners (MATEP) adherence initiative: Rationale and goals
25. Adherence: A necessity for successful HIV combination therapy
26. - youth
27. Rethinking non-adherence: Historical perspectives on triple-drug therapy for HIV disease
28. Strategies to optimise adherence to highly active antiretroviral treatment
29. The impact of the ALR alarm device on antiretroviral adherence among HIV-infected outpatients in Harlem
30. + persons
31. Perceived health care providers support and HIV adherence
32. Consequences of intermittent treatment for hypertension: The case for medication compliance and persistence